Tag Archives: Gilead Sciences

Healthcare Sector News Buzz: Mylan (NASDAQ:MYL), Gilead Sciences (NASDAQ:GILD) – MYL, GILD, PFE, QCOR, BKD, AVEO

Posted on May 3, 2013 by Thomas Vedder

Investors responded positively to the healthcare stocks on Thursday. Key movement were observed in Questcor Pharmaceuticals Inc (NASDAQ:QCOR) and Brookdale Senior Living, Inc (NYSE:BKD) on percentage gainers side while AVEO Pharmaceuticals, Inc (NASDAQ:AVEO) was prominent stock on percentage decliner side.…

Investors Watch List: First Solar (NASDAQ:FSLR), Gilead Sciences (NASDAQ:GILD)

Posted on April 10, 2013 by Thomas Vedder

First Solar, Inc (NASDAQ:FSLR) announced on Tuesday that it projects fiscal year 2013 revenue and earnings that surpassed analysts’ estimates amid a rosy guidance for its power-plant development unit, and the corporation unveiled a new type of panel it intends …

Posted in Latest Headlines | Tagged First Solar, FSLR, GILD, Gilead Sciences, NASDAQ:FSLR, NASDAQ:GILD | Comments Off

Key Movers in Healthcare Sector: Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE) – GILD, PFE, BMY, RPRX, NBIX, JNJ

Posted on March 29, 2013 by Thomas Vedder

Investors responded positively to the healthcare stocks on Thursday. Key movement were monitored in Repros Therapeutics Inc (NASDAQ:RPRX) and Neurocrine Biosciences, Inc (NASDAQ:NBIX) on percentage gainers side while Johnson & Johnson (NYSE:JNJ) and Gilead Sciences, Inc (NASDAQ:GILD) were most active …

Posted in Healthcare, Latest Headlines | Tagged BMY, Bristol-Myers Squibb, GILD, Gilead Sciences, JNJ, Johnson, NASDAQ:GILD, NASDAQ:NBIX, NASDAQ:RPRX, NBIX, Neurocrine Biosciences, NYSE:BMY, NYSE:JNJ, NYSE:PFE, PFE, Pfizer, Repros Therapeutics, RPRX | Comments Off

Health Perfect Stocks Alert; Gilead Sciences Inc. (NASDAQ:GILD) and Johnson & Johnson’s (NYSE:JNJ)

Posted on March 5, 2013 by Geoff Noir

Johnson & Johnson’s (NYSE:JNJ) Janssen Research & Development LLC reported that the US Food and Drug Administration once more refused the acceptance of its blood thinner Xarelto for patients with a heart problem called as acute coronary syndrome.

The FDA …

Posted in Latest Headlines | Tagged GILD, Gilead Sciences, JNJ, Johnson & Johnson, NASDAQ:GILD, NYSE:JNJ | Comments Off

Gilead Sciences (NASDAQ:GILD) Completes Acquisition of YM BioSciences (YMI) – GILD, MRK, BMY, JNJ

Posted on February 9, 2013 by Thomas Vedder

Gilead Sciences, Inc (NASDAQ:GILD) reported on Friday that it has done it’s almost $510 million purchase of Mississauga, Canada-based YM BioSciences Inc (USA) (NYSEAMEX:YMI).

Biopharmaceuticals firm Gilead reported that its subsidiary has purchased all of the outstanding common shares of …

Posted in Healthcare, Latest Headlines | Tagged BMY, Bristol-Myers Squibb, GILD, Gilead Sciences, JNJ, Johnson, Merck, MRK, NASDAQ:GILD, NYSE:BMY, NYSE:JNJ, NYSE:MRK | Comments Off

HUMHumana (NYSE:HUM) Declares fiscal Q4 Results; Earnings Hikes 3.5% – HUM, KERX, GILD, BSX, PPHM, MRK, HLF, AET, CI

Posted on February 4, 2013 by Geoff Noir

Humana Inc (NYSE:HUM) announced on Monday that fiscal Q4 earnings moved down 3.5 percent as higher coverage outlays masked firm’s revenue expansion from higher membership.

The health-care company done it’s almost $850 million purchase of Metropolitan Health Networks Inc in …

Posted in Healthcare, Latest Headlines | Tagged AET, Aetna, Boston Scientific, BSX, CI, Cigna, GILD, Gilead Sciences, Herbalife, HLF, HUM, Humana, KERX, Keryx Biopharmaceuticals, Merck, MRK, NASDAQ:GILD, NASDAQ:KERX, NASDAQ:PPHM, NYSE:AET, NYSE:BSX, NYSE:CI, NYSE:HLF, NYSE:HUM, NYSE:MRK, Peregrine Pharmaceuticals, PPHM | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.